Showing results (121-130 of 218) with videos related to
Sort By:
Pageof 22
Cell|December 2, 2017
Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung CancerMichael J Topper, Michelle Vaz, Katherine B Chiappinelli, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2021
Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell lung cancerA J Schoenfeld, S J Antonia, M M Awad, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 18, 2020
Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomasA J Schoenfeld, H Rizvi, C Bandlamudi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2018
Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung CancerKathryn C Arbour, Laura Mezquita, Niamh Long, et al.British Journal of Cancer|March 31, 2017
Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortiumT Goranova, D Ennis, A M Piskorz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2020
Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti-PD-(L)1 TherapyMatthew D Hellmann, Pasi A Jänne, Mateusz Opyrchal, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2019
Lesion-Level Response Dynamics to Programmed Cell Death Protein (PD-1) BlockadeJuan C Osorio, Kathryn C Arbour, Dung T Le, et al.Nature Communications|August 1, 2020
Escape from nonsense-mediated decay associates with anti-tumor immunogenicityKevin Litchfield, James L Reading, Emilia L Lim, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 21, 2019
Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized CohortNeal E Ready, Patrick A Ott, Matthew D Hellmann, et al.British Journal of Cancer|March 14, 2019
Correction: Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortiumT Goranova, D Ennis, A M Piskorz, et al.Pageof 22